AGILE FOREIGN EXCHANGE LIMITED

Executive Summary

AGILE FOREIGN EXCHANGE LIMITED currently shows no trading activity or financial transactions across four years, with zero assets and liabilities, reflecting a dormant or non-operational status despite being legally active. Overdue financial filings indicate compliance risks. Immediate action to regularize filings and clarify business strategy is essential to restore financial health and avoid regulatory consequences.

View Full Analysis Report →

Company Analysis

This analysis is opinion only and should not be interpreted as financial advice.

AGILE FOREIGN EXCHANGE LIMITED - Analysis Report

Company Number: 12609614

Analysis Date: 2025-07-20 16:25 UTC

Financial Health Assessment of AGILE FOREIGN EXCHANGE LIMITED


1. Financial Health Score: F

Explanation:
The company shows no recorded assets, liabilities, or equity across four consecutive financial years, with zero turnover and no financial activity reported. This is a critical red flag indicating a lack of operational business activity or financial transactions. The overdue filing of accounts further compounds concerns about compliance and governance. Overall, this paints a picture of a financially inactive or dormant company despite the "Active" status.


2. Key Vital Signs

Metric Latest Data (31 May 2023) Interpretation
Fixed Assets £0 No long-term investments or property held
Current Assets £0 No cash, receivables, or short-term assets
Current Liabilities £0 No short-term debts or payables
Net Current Assets £0 Neutral working capital; no operational liquidity
Total Assets Less Current Liabilities £0 No net tangible asset base
Net Assets / Shareholders Funds £0 No equity or retained earnings; company shows zero net worth
Share Capital £100 Minimal initial funding
Employees 1 Minimal staffing
Accounts Filing Status Overdue Compliance risk, potential penalties
Company Status Active Company legally exists but shows no trading activity

3. Diagnosis: Symptoms Analysis and Overall Financial Condition

  • Symptoms of Distress or Dormancy:
    The absence of any assets, liabilities, or equity over four years is a classic symptom of dormancy or non-trading status. However, the company is still listed as "Active," which suggests a mismatch between legal status and operational reality. The lack of cash or receivables indicates no trading revenues or ongoing business operations.

  • Compliance Concerns:
    Overdue accounts filing signifies governance weaknesses or potential neglect. This non-compliance can lead to regulatory penalties, reputational damage, and risk of enforcement action.

  • Operational Health:
    With only one employee (likely the director) and no financial transactions, the business is not generating income or incurring expenses. This lack of activity might be strategic (e.g., holding company, preparatory stage) or symptomatic of business inactivity.

  • Liquidity and Solvency:
    The company shows no assets or liabilities, so liquidity and solvency cannot be meaningfully assessed. However, the lack of cash or net assets implies it cannot meet obligations beyond minimal operating costs if needed.

  • Future Viability:
    Without evidence of capital infusion, trading activity, or financial growth, the company’s future viability is questionable. If the current state persists, it risks forced strike-off or voluntary dissolution unless reactivated.


4. Recommendations: Improving Financial Wellness

  1. Regularize Compliance Immediately:
    Submit overdue accounts and ensure all future filings are timely to avoid penalties and maintain good standing with Companies House.

  2. Clarify Business Model and Activity:
    If the company is intended to trade, initiate operations, generate revenue, and record financial transactions to reflect active business health. If dormant, consider filing dormant company accounts to reduce administrative burden.

  3. Financial Record-Keeping:
    Maintain proper accounting records to capture any transactions, however minimal. This will facilitate accurate financial reporting and compliance.

  4. Capital Infusion:
    Consider injecting additional capital or securing funding to support start-up costs or operational needs if business activation is planned.

  5. Strategic Review:
    Evaluate whether continuing as a private limited company is appropriate. If the company is inactive for strategic reasons, formalize this status to avoid regulatory complications.

  6. Director Oversight:
    The director should ensure active oversight of company affairs, compliance, and financial reporting to prevent further deterioration of company health.



More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company